Osteoarthritis pain and hypertension treatment by end of year

Israeli biotech Kitov has announced that it will be ready at the end of 2016 to launch its KIT-302 treatment for osteoarthritis pain and hypertension simultaneously.  Dexcel will mass-produce and market the treatment.


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *